Company Filing History:
Years Active: 2018-2022
Title: Jörg Goldhahn: Innovator in Cartilage Treatment and Muscle Recovery
Introduction
Jörg Goldhahn is a prominent inventor based in Walbach, Switzerland. He has made significant contributions to the fields of cartilage treatment and muscle recovery, holding 2 patents that reflect his innovative approach to medical challenges.
Latest Patents
Goldhahn's latest patents include groundbreaking methods and compositions for the treatment of cartilage damage and arthritis. This invention provides methods and compositions for treating cartilage damage or arthritis through the administration of a protease-resistant ANGPTL3 polypeptide with chondrogenic activity. Additionally, he has developed a patent related to the administration of bimagrumab for improving muscle mass and function after hip fracture surgery. This disclosure outlines uses and regimens for accelerating physical recovery in patients experiencing disuse atrophy due to reduced mobility from a hip fracture and subsequent major surgery. It employs a therapeutically effective amount of a myostatin antagonist, such as a myostatin binding molecule or an ActRII receptor binding molecule.
Career Highlights
Goldhahn's career is marked by his dedication to advancing medical science through innovative solutions. His work at Novartis AG has positioned him as a key player in the development of therapies that address significant health issues.
Collaborations
He collaborates with talented professionals, including Kristen Johnson and Celeste Scotti, to further enhance the impact of his inventions.
Conclusion
Jörg Goldhahn's contributions to the medical field through his patents demonstrate his commitment to improving patient outcomes. His innovative methods for treating cartilage damage and enhancing muscle recovery are paving the way for future advancements in healthcare.